| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0959-437X(99)00048-9 |
| P698 | PubMed publication ID | 10679393 |
| P2093 | author name string | Green DR | |
| Pinkoski MJ | |||
| P2860 | cites work | Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer | Q22008593 |
| Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II | Q22010404 | ||
| Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis | Q24324204 | ||
| Immune response and myoblasts that express Fas ligand | Q73974840 | ||
| Tumor expression of Fas ligand (CD95L) and the consequences | Q77485532 | ||
| Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion | Q77847672 | ||
| Fas ligand: a sensor for DNA damage critical in skin cancer etiology | Q78095125 | ||
| Fas-ligand: privilege and peril | Q24612227 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease | Q28115268 | ||
| Signalling through phosphoinositide 3-kinases: the lipids take centre stage | Q28141934 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| Regulation of cell death protease caspase-9 by phosphorylation | Q28288607 | ||
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN | Q28513537 | ||
| Caspases: enemies within | Q29547315 | ||
| New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Q29616144 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| The Fas counterattack: cancer as a site of immune privilege | Q33542332 | ||
| PTEN: a tumour suppressor that functions as a phospholipid phosphatase | Q33594251 | ||
| Suicidal tendencies: apoptotic cell death by caspase family proteinases | Q33684353 | ||
| Fas ligand, death gene. | Q33818624 | ||
| Oncogenic Ras inhibits Fas ligand-mediated apoptosis by downregulating the expression of Fas. | Q33890659 | ||
| Ras signalling and apoptosis | Q34746668 | ||
| Apoptotic pathways: the roads to ruin | Q34753431 | ||
| Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase | Q35785971 | ||
| Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. | Q36107808 | ||
| Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover | Q36236704 | ||
| Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils | Q36367140 | ||
| Transforming growth factor beta1 inhibits Fas ligand expression and subsequent activation-induced cell death in T cells via downregulation of c-Myc | Q36367920 | ||
| A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation | Q36368071 | ||
| Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity | Q36400613 | ||
| Fas and Fas ligand interactions suppress melanoma lung metastasis | Q36401618 | ||
| Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis | Q36404144 | ||
| A vision of cell death: insights into immune privilege | Q40898578 | ||
| Regulation of the proinflammatory effects of Fas ligand (CD95L). | Q40992162 | ||
| Downregulation of Fas ligand by shedding | Q41071790 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| Systemic autoimmune disease as a consequence of defective lymphocyte death | Q41716668 | ||
| Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. | Q42824933 | ||
| Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. | Q42830166 | ||
| Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells | Q46642536 | ||
| Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. | Q46925453 | ||
| Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. | Q52532134 | ||
| Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. | Q53425055 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis | Q56922123 | ||
| High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice | Q58378937 | ||
| Impaired Fas response and autoimmunity in Pten+/- mice | Q73019160 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 114-119 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | Cloak and dagger in the avoidance of immune surveillance | |
| P478 | volume | 10 |
| Q24299590 | Defects in death-inducing signalling complex formation prevent JNK activation and Fas-mediated apoptosis in DU 145 prostate carcinoma cells |
| Q35538226 | Live and let die: regulatory mechanisms in Fas-mediated apoptosis. |
| Q35700363 | Opposite phenotypes of cancer and aging arise from alternative regulation of common signaling pathways |
| Q44611177 | Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL |
| Q39017874 | RGD-FasL induces apoptosis in hepatocellular carcinoma |
Search more.